Back to Results
First PageMeta Content
Alkaloids / Benzoates / Carbamates / Docetaxel / Lung cancer / Prostate cancer / Angiogenesis / Vascular-targeting agent / Tyrosine kinase inhibitors / Medicine / Chemistry / Organic chemistry


Microsoft Word - NPI[removed]ADVANCE PR FINAL.docx
Add to Reading List

Document Date: 2011-08-15 11:58:23


Open Document

File Size: 16,39 KB

Share Result on Facebook

City

Boston / SAN DIEGO / /

Company

Nereus Pharmaceuticals Inc. / President & CEO Nereus Pharmaceuticals Inc. / Nereus Pharmaceuticals / /

Continent

South America / /

Country

United States / Australia / India / /

/

Event

FDA Phase / /

IndustryTerm

cancer therapies / treatment of cancer / chemical diversity / Cancer Therapeutics / cancer treatment / /

MedicalCondition

cancers / tumor / squamous cell carcinoma / cancer / multiple myeloma / tumors / NSCLC / standard cancer / solid tumors / lymphomas / hemorrhagic tumor necrosis / sarcoma / nonsmall cell lung cancer / Non-Small Cell Lung Cancer / infectious diseases / advanced non-small cell lung cancer / leukemias / inflammation / established tumor / /

MedicalTreatment

oncology therapies / cancer therapies / chemotherapy / /

Organization

Massachusetts General Hospital Cancer Center / /

Person

Kobi Sethna / Rebecca Heist / /

/

Position

lead author / Assistant Professor / Investor Relations Porter / /

Product

Plinabulin / /

ProvinceOrState

California / Massachusetts / /

TVStation

Kobi / /

Technology

pharmacokinetics / drug discovery / polymerization / chemotherapy / /

URL

www.nereuspharm.com / /

SocialTag